Assura PLC Notice of dividend (6622J)

TIDMAGR

RNS Number : 6622J

Assura PLC

06 December 2018

6 December 2018

Assura plc

Notice of Dividend

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.685 pence per share will be paid on 16 January 2019 to shareholders on the register on 14 December 2018 (the "Record Date"). The Ex-dividend Date will be 13 December 2018.

This interim dividend will be a normal dividend (Non-PID). Please refer to Company's website HERE for more information.

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 20 December 2018.

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 2 January 2019 either to return their completed mandate form to the Company registrars, Link Asset Services at The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

The Circular concerning this Scrip Dividend Alternative is available on the Company's website, www.assuraplc.com and is also available for inspection at the National Storage Mechanism http://www.morningstar.co.uk/uk/NSM.

- Ends -

For more information, please contact:

 
 
    Assura plc    Tel: [phone] 
  Orla Ball 
 
    Edelman 
    John Kiely    Tel: [phone] 
  Rob Yates 
 
 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2018, Assura's property portfolio was valued at GBP1,843 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DIVEANAKEASPFEF

(END) Dow Jones Newswires

December 06, 2018 04:30 ET (09:30 GMT)